XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Bitcoin Futures Open Interest Falls $1.4B as Spot Buyers Step In
Futures open interest measures the total value of outstanding derivative contracts that have not been settled. When that figure contracts, it typically signals...
Morgan Stanley Bitcoin ETF Tops 10,500 BTC
Morgan Stanley’s Bitcoin ETF has crossed the 10,500 BTC threshold, marking a notable accumulation milestone for the Wall Street firm’s spot Bitcoin fund. The ho...
CFTC Opens ANPRM for Federal Leveraged Retail Crypto Trading Framework
The Commodity Futures Trading Commission has opened an Advance Notice of Proposed Rulemaking, or ANPRM, seeking public input on a potential federal framework go...
ZachXBT Traces $12M in Bybit Exploit Funds
On-chain investigator ZachXBT says posing as a prospective client gave him access to a money-laundering network that helped him trace more than $12 million in f...
OKX and ICE File to Trade 63 Tokenized NYSE Stocks
OKX and Intercontinental Exchange have filed to offer trading in 63 tokenized NYSE-listed stocks, marking one of the largest tokenized equity proposals to date...
Metaplanet Sold 10,000 Bitcoin to Show Reserves Could Top Debt
Metaplanet sold 10,000 Bitcoin during the July-to-September quarter and later repurchased 11,000 BTC, according to an Oct. 5 exchange filing.
